// App-Quantinova.ai

BSH2020‐OR‐027 : Real‐world data of high‐grade lymphoma patients treated with CD19 CAR‐T in the UK

Researchers

Presenter

  • A. Kuhnl

Principal Investigators

  • E. Tholouli

  • T. Menne

  • K. Linton

  • S. Lugthart

  • S. Chaganti

  • R. Sanderson

  • M. O'Reilly

  • J. Norman

  • W. Osborne

  • J. Radford

  • C. Besley

  • R. Malladi

  • P. Patten

  • M. Marzolini

  • N. Martinez-Cibrian

  • G. Shenton

  • A. Bloor

  • S. Robinson

  • C. Rowntree

  • D. Irvine

  • C. Burton

  • B. Uttenthal

  • S. Iyengar

  • O. Stewart

  • W. Townsend

  • K. Cwynarski

  • K. Ardeshna

  • A. Ardavan

  • K. Robinson

  • T. Pagliuca

  • K. Bowles

  • G. Collins

  • R. Johson

  • A. McMillan

Medical Centers

  • Haematology, Kings College Hospital, London,

  • Haematology Department, University College London Hospitals, London, UK

  • Haematology, Manchester Royal Infirmary,

  • Haematology, Freeman Hospital Newcastle, Newcastle Upon Tyne, UK

  • Clinical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK

  • Haematology, Bristol University Hospital, Bristol

  • Haematology, Queen Elizabeth Hospital, Birmingham

  • Haematology, Wales University Hospital, Cardiff

  • Haematology, Queen Elizabeth University Hospital, Glasgow

  • Haematology, St James's University Hospital, Leeds

  • Haematology, Addenbrooke's Hospital, Cambridge

  • Haematology, Royal Marsden Hospital

  • NCRI Consumer Forum, London

  • Haematology, Norfolk and Norwich University Hospital NHS Foundation Trust, London

  • Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford

  • Rhuematology, Nottingham University NHS Trust, Nottingham, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lymphomas

Biomarkers

  • Cluster of Differentiation 19

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • Axicabtagene ciloleucel

  • tisagenlecleucel-t

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A